Cairo: Industry Minister Khaled Hashem announced the government's initiative to promote modern technology and specialized expertise in the pharmaceutical sector. The goal is to produce high-quality, innovative medicines to meet domestic demand and support export market expansion.
According to State Information Service Egypt, Hashem emphasized the ministry's plan to adopt effective mechanisms for facilitating export procedures, in coordination with relevant ministries and authorities. These measures aim to accelerate customs approvals, streamline quality certifications, and reduce routine procedures, thereby ensuring smoother export operations and enhancing factories' capabilities to efficiently meet foreign demand.
During a field tour of five pharmaceutical manufacturing plants in Obour Industrial City, Qalyubia province, Hashem elaborated on these strategies. This visit is part of a broader initiative to inspect factories and industrial zones to monitor production processes, identify manufacturers' needs, and explore support and development pathways for the pharmaceutical sector to boost local demand and exports.
The tour began with a visit to the Global Pharmaceutical Industries Company 'Unipharma,' covering 10,000 square meters with a capital of 100 million Egyptian pounds. The plant, which has a local component ratio of about 60%, provides over 500 jobs and exported goods worth 27.8 million pounds in 2025.
Hashem then visited the Amoun Pharmaceuticals plant, a part of Aresira Global Life Sciences, which spans over 58,000 square meters with investments of around 9 billion pounds. The plant boasts an annual production capacity of 333 million packs, a local component ratio of 30%, and provides approximately 2,700 jobs. Its exports reached 850 million pounds in 2025.
The tour included Markerel Pharmaceutical Industries, occupying 11,500 square meters with expansions for a new 11,200 square meter factory. With a capital of 350 million pounds and a monthly production capacity of 12 million units, the plant employs about 2,200 workers and recorded exports of 814 million pounds in 2025.
Hashem's tour also covered the Orchidya Pharmaceutical Industries plant, which spans 6,000 square meters with a capital of 500 million pounds and total investments exceeding 2.07 billion pounds. The facility has an annual production capacity of 90 million units, a local component ratio of 80%, and provides about 630 jobs. Its exports reached 620 million pounds in 2025.
The minister concluded his visit at the Jamjoom Pharma plant, built on 15,500 square meters with investments exceeding $70 million. The plant has an annual production capacity of around 73 million packs and provides about 350 jobs. Hashem reviewed the facility's tablet and capsule production lines, cream and ointment packaging lines, and the quality and safety standards applied throughout the manufacturing stages.